BriaCell Therapeutics Corp.
BCTX · NASDAQ
7/31/2025 | 7/31/2024 | 7/31/2023 | 7/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$36,495 | -$6,547 | -$27,268 | -$34,127 |
| Dep. & Amort. | $148 | $115 | $21 | $19 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$2,645 | $9,638 | -$4,744 | -$498 |
| Other Non-Cash | -$80 | -$36,173 | $100 | $18,730 |
| Operating Cash Flow | -$39,073 | -$32,968 | -$31,891 | -$15,874 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$624 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$10,605 | -$307 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$10,605 | -$932 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $63,038 | $6,038 | $5,374 | $8,205 |
| Stock Repurch. | $0 | $0 | -$64 | -$12,934 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | -$30 |
| Financing Cash Flow | $63,038 | $6,038 | $5,311 | -$4,759 |
| Forex Effect | -$120 | -$372 | $329 | -$132 |
| Net Chg. in Cash | $13,240 | -$28,233 | -$26,252 | -$20,765 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,188 | $29,430 | $54,250 | $73,446 |
| End Cash | $14,428 | $1,197 | $27,998 | $52,680 |
| Free Cash Flow | -$39,073 | -$33,592 | -$31,891 | -$15,874 |